Reversal of dabigatran by intraosseous or intravenous idarucizumab in a porcine polytrauma model

Intravenous and intraosseous idarucizumab were comparable for reversing dabigatran in a porcine trauma model. Dabigatran reversal could be monitored using fully automated thromboelastography.